1010837-60-1

Basic information

• Product Name: 1H-IMidazole, 2-(4-broMophenyl)-5-(trifluoroMethyl)-
• Synonyms: 1H-IMidazole, 2-(4-broMophenyl)-5-(trifluoroMethyl)-;2-(4-BroMophenyl)-4(5)-(trifluoroMethyl)iMidazole;2-(4-bromophenyl)-5-(trifluoromethyl)-1H-Imidazole
• CAS NO: 1010837-60-1
• Molecular Formula: C₁₀H₆BrF₃N₂
• Molecular Weight: 291.0672496
• Mol File: 1010837-60-1.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-IMidazole, 2-(4-broMophenyl)-5-(trifluoroMethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-IMidazole, 2-(4-broMophenyl)-5-(trifluoroMethyl)-(1010837-60-1)
• EPA Substance Registry System: 1H-IMidazole, 2-(4-broMophenyl)-5-(trifluoroMethyl)-(1010837-60-1)

Safety Data

• Hazardous Substances Data: 1010837-60-1(Hazardous Substances Data)

Usage

General Description

1H-Imidazole, 2-(4-bromophenyl)-5-(trifluoromethyl)- is a chemical compound with the molecular formula C11H8BrF3N2. It is a derivative of imidazole, containing a bromophenyl group and a trifluoromethyl group. 1H-IMidazole, 2-(4-broMophenyl)-5-(trifluoroMethyl)- is commonly used in pharmaceutical research and drug development due to its diverse biochemical and pharmacological properties. It has been studied for its potential applications in the treatment of various diseases and conditions, including cancer and neurological disorders. The presence of the bromophenyl and trifluoromethyl groups in this compound may contribute to its specific molecular interactions and biological activities, making it a valuable molecule for further investigation and potential therapeutic use.

Upstream product

• 1122-91-4 4-bromo-benzaldehyde 
• 431-67-4 1,1-dibromo-3,3,3-trifluoroacetone 

Downstream Products

• 1383001-02-2 1-benzyl-2-(4-bromophenyl)-4-(trifluoromethyl)-1H-imidazole 
• 883232-16-4 C₁₆H₁₀BrF₃N₂ 

Relevant articles and documents

Discovery of novel 2-aryl-4-bis-amide imidazoles (ABAI) as anti-inflammatory agents for the treatment of inflammatory bowel diseases (IBD)

A series of 2-Aryl-4-Bis-amide Imidazoles (ABAI-1 to 30) were designed as anti-inflammatory agents. These compounds were synthesized and evaluated for the in vitro anti-inflammatory activities (inhibition of NO production and release of inflammatory cytok

CONTINUOUS ARYCYCLIC COMPOUND

This is to provide a continuous arycyclic compound having a DGAT1 inhibitory activity, and useful for prophylaxis and/or treatment of obesity or hyperlipidemia caused by obesity, hypertriglyceridemia, lipid metabolism disorder, fatty liver, hypertension,